Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
United States
Lurie Children's Hospital of Chicago, Chicago, Illinois Our Lady of the Lake Children's Hospital, Baton Rouge, Louisiana Dana Farber Cancer Institute, Boston, Massachusetts Washington University Medical Center, St Louis, Missouri Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio St. Jude Children's Research Hospital, Memphis, Tennessee